MiR-216b inhibits pancreatic cancer cell progression and promotes apoptosis by down-regulating KRAS

MiR-216b inhibits pancreatic cancer cell progression and promotes apoptosis by down-regulating KRAS

Bibliographic Details
Main Authors:	Xinquan Wu, Weibo Chen, Huihua Cai, Jun Hu, Baoqiang Wu, Yong Jiang, Xuemin Chen, Donglin Sun, Yong An
Format:	Article
Language:	English
Published:	Termedia Publishing House 2017-12-01
Series:	Archives of Medical Science
Subjects:	pancreatic cancer miR-216b <i>KRAS</i>
Online Access:	https://www.termedia.pl/MiR-216b-inhibits-pancreatic-cancer-cell-progression-and-promotes-apoptosis-by-down-regulating-KRAS,19,31431,1,1.html

Similar Items

miR-216b Post-Transcriptionally Downregulates Oncogene KRAS and Inhibits Cell Proliferation and Invasion in Clear Cell Renal Cell Carcinoma
by: Yan Wang, et al.
Published: (2018-09-01)

Eicosapentaenoic Acid Inhibits <i>KRAS</i> Mutant PancreaticCancer Cell Growth by Suppressing Hepassocin Expression and STAT3 Phosphorylation
by: Ching-Feng Chiu, et al.
Published: (2021-03-01)

MiR-216b inhibits gastric cancer proliferation and migration by targeting PARK7
by: Guo-Min Zhu, et al.
Published: (2021-01-01)

Isoflurane Suppresses Proliferation, Migration, and Invasion and Facilitates Apoptosis in Colorectal Cancer Cells Through Targeting miR-216
by: Zhe Cai, et al.
Published: (2021-08-01)

Zebrafish model of KRAS-initiated pancreatic cancer
by: Joon Tae Park, et al.
Published: (2018-11-01)

Biological functions of microRNA-216 and microRNA-217 during the development of pancreatic cancer
by: Azevedo-Pouly, Ana Clara P.
Published: (2013)

Inhibition of lncRNA LINC00461/miR-216a/aquaporin 4 pathway suppresses cell proliferation, migration, invasion, and chemoresistance in glioma
by: Peng Yanguo, et al.
Published: (2020-07-01)

MiR-216b suppresses colorectal cancer proliferation, migration, and invasion by targeting SRPK1
by: Yao YF, et al.
Published: (2018-03-01)

<i>KRAS</i> Mutation Dictates the Cancer Immune Environment in Pancreatic Ductal Adenocarcinoma and Other Adenocarcinomas
by: Meichen Gu, et al.
Published: (2021-05-01)

miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins
by: Sun Y, et al.
Published: (2018-10-01)

LncRNA DANCR silence inhibits SOX5-medicated progression and autophagy in osteosarcoma via regulating miR-216a-5p
by: Zhengxia Pan, et al.
Published: (2020-02-01)

lncRNA DSCAM-AS1 downregulates miR-216b to promote the migration and invasion of colorectal adenocarcinoma cells
by: Liu F, et al.
Published: (2019-08-01)

Zebrafish model of KRAS-initiated pancreatic endocrine tumor
by: Sekyung Oh, et al.
Published: (2019-05-01)

MiR-216b suppresses cell proliferation, migration, invasion, and epithelial–mesenchymal transition by regulating FOXM1 expression in human non-small cell lung cancer
by: Wang L, et al.
Published: (2019-04-01)

MiR-216a-5p targets TCTN1 to inhibit cell proliferation and induce apoptosis in esophageal squamous cell carcinoma
by: Lixun Chai, et al.
Published: (2019-06-01)

Autophagy induced during pancreatitis promotes KRAS-dependent transformation in the pancreas
by: Juan Iovanna
Published: (2016-10-01)

siRNA-Loaded Hydroxyapatite Nanoparticles for <i>KRAS</i> Gene Silencing in Anti-Pancreatic Cancer Therapy
by: Dandan Luo, et al.
Published: (2021-09-01)

LncRNA CTBP1-AS2 regulates miR-216a/ PTEN to suppress ovarian cancer cell proliferation
by: Kaiying Cui, et al.
Published: (2020-07-01)

Limonin attenuates the stemness of breast cancer cells via suppressing MIR216A methylation
by: Zhou Su, et al.
Published: (2019-04-01)

HOTTIP Predicts Poor Survival in Gastric Cancer Patients and Contributes to Cisplatin Resistance by Sponging miR-216a-5p
by: Rui Zhao, et al.
Published: (2020-05-01)

Circ_0029803 serves as the sponge of miR-216b-5p to promote the progression of colorectal cancer by regulating SKIL expression
by: Linfei Huang, et al.
Published: (2021-09-01)

Beyond KRAS: Practical Molecular Targets in Pancreatic Adenocarcinoma
by: Albert Grinshpun, et al.
Published: (2019-01-01)

Targeting Mutant <i>KRAS</i> in Pancreatic Cancer: Futile or Promising?
by: Friederike Inga Nollmann, et al.
Published: (2020-08-01)

MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS
by: Fei Xie, et al.
Published: (2019-11-01)

LncRNA CTBP1-AS2 sponges miR-216a to upregulate PTEN and suppress endometrial cancer cell invasion and migration
by: Qing-an-zi Wang, et al.
Published: (2020-04-01)

Differentiation antagonizing non-protein coding RNA modulates the proliferation, migration, and angiogenesis of glioma cells by targeting the miR-216a/LGR5 axis and the PI3K/AKT signaling pathway
by: Wang W, et al.
Published: (2019-04-01)

Kras mutation correlating with circulating regulatory T cells predicts the prognosis of advanced pancreatic cancer patients
by: He Cheng, et al.
Published: (2020-03-01)

Long non-coding RNA TUG1 promotes cell progression in hepatocellular carcinoma via regulating miR-216b-5p/DLX2 axis
by: Qun Dai, et al.
Published: (2020-01-01)

Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer
by: Masayuki Hiraki, et al.
Published: (2015-01-01)

The Diagnostic Accuracy of Mutant KRAS Detection from Pancreatic Secretions for the Diagnosis of Pancreatic Cancer: A Meta-Analysis
by: Nikhil Patel, et al.
Published: (2020-08-01)

Overview on how oncogenic Kras promotes pancreatic carcinogenesis by inducing low intracellular ROS levels
by: Bo eKong, et al.
Published: (2013-09-01)

CircFBXL5 promotes the 5-FU resistance of breast cancer via modulating miR-216b/HMGA2 axis
by: Mingzhi Zhu, et al.
Published: (2021-07-01)

MicroRNA-216a promotes the metastasis and epithelial–mesenchymal transition of ovarian cancer by suppressing the PTEN/AKT pathway
by: Liu H, et al.
Published: (2017-05-01)

Matrine suppresses KRAS‐driven pancreatic cancer growth by inhibiting autophagy‐mediated energy metabolism
by: Young‐ra Cho, et al.
Published: (2018-06-01)

Concordance of KRAS mutation status between luminal and peripheral regions of primary colorectal cancer. A laser-capture microdissection-based study
by: Magdalena Lewandowska, et al.
Published: (2016-05-01)

Overexpression of microRNA-216a inhibits autophagy by targeting regulated MAP1S in colorectal cancer
by: Wang Y, et al.
Published: (2019-06-01)

EGFR and KRAS Mutations in the Non-Tumoral Lung. Prognosis in Patients with Adenocarcinoma
by: Roberto Chalela, et al.
Published: (2019-04-01)

Atmospheric Abundances, Trends and Emissions of CFC-216ba, CFC-216ca and HCFC-225ca
by: Corinna Kloss, et al.
Published: (2014-06-01)

KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities
by: Claudio Luchini, et al.
Published: (2020-10-01)

Expression of JAK2 and MicroRNA-216a in Patients with Acute Myeloid Leukemia
by: Nazanin Seyedesmaeili, et al.
Published: (2018-07-01)